Nuvectis Pharma, Inc. Cash Flow Statement

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2021	Dec2022	Dec2023	Dec2024
Operating Activities
Net Income	-12.89M	-19.09M	-22.26M	-19.00M
Share-based Compensation	1.89M	1.71M	4.71M	4.86M
Cash from Operations	-9.50M	-13.56M	-15.95M	-12.25M
Change in Working Capital
Change in Account Payables		1.85M	-0.14M	-0.27M
Change in Accured Expenses	1.58M	1.95M	1.42M	1.76M
Financing Activities
Other financing activities	1.89M	1.71M	0.17M	0.38M
Change in Capital Stock
Shares Issued		16.00M	11.19M	12.04M
Preferred Shares Issued	15.25M
Misc.
Cash from Financing Activities	15.25M	27.81M	15.09M	11.65M
Change in Cash	5.74M	14.25M	-0.87M	-0.59M
Free Cash Flow	-9.50M	-13.56M	-15.95M	-12.25M
Net Cash Flow	5.74M	14.25M	-0.87M	-0.59M